Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies (P4-14.008) von Seth, Nilufer, Xu, Rui, Tyler, Steven, Avery, William, Beavers, Traymon, Prage, Viraj, Sihapong, Sam, Brown, Julia, Bhattacharya, Sayak, Ramchandren, Sindhu, Heerlein, Kristin, Sun, Hong, Abouzahr, Katie, Ling, Leona

Volltext

Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD von Abouzahr, Katie

Volltext

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties von Seth, Nilufer P, Xu, Rui, DuPrie, Matthew, Choudhury, Amit, Sihapong, Samuel, Tyler, Steven, Meador, James, Avery, William, Cochran, Edward, Daly, Thomas, Brown, Julia, Rutitzky, Laura, Markowitz, Lynn, Kumar, Sujatha, Beavers, Traymon, Bhattacharya, Sayak, Chen, Hsin, Parge, Viraj, Price, Karen, Wang, Yang, Sukumaran, Siddharth, Pao, Yvonne, Abouzahr, Katie, Elwood, Fiona, Duffner, Jay, Roy, Sucharita, Narayanaswami, Pushpa, Hubbard, Jonathan J, Ling, Leona E

Volltext

A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19 von Chitty, Stephen A, Mobbs, Sarah, Rifkin, Brian S, Stogner, Steven W, Lewis, Michael S, Betancourt, Jaime, DellaVolpe, Jeffrey, Abouzahr, Fadi, Wilhelm, Andrew M, Szerlip, Harold M, Parikh, Amay, Gaeta, Robert M, Rivera, Ian, Park, Caroline, Levi, Benjamin, Anesi, George L, Alcover, Karl C, Arnold, Thomas B, Howard, Jeffrey T, Sharma, Kumar, Pratt, Kathleen P, Stewart, Ian J, Chung, Kevin K

Volltext